Lion Firms Up Post-Trega Plan; Layoffs, New Hires Mark Cheminformatics Focus | GenomeWeb

Lion Bioscience’s decision last week to lay off approximately 25 people from its staff of 120 at its San Diego operation, formerly Trega Biosciences, was spurred by the need to limit Trega’s focus to better match Lion’s business model, said Friedrich von Bohlen, CEO of Lion.

“In San Diego we offered three types of services: software, discovery, and a combinatorial library. We decided that combinatorial chemistry is not our core business,” said von Bohlen. “We decided to stay with our focus and reduce our activities in the combinatorial chemistry business.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.